Published in Atherosclerosis on September 01, 2001
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med (2009) 2.52
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin Exp Immunol (2004) 1.00
HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection. BMC Cardiovasc Disord (2003) 0.82
Transgelin 2 participates in lovastatin-induced anti-angiogenic effects in endothelial cells through a phosphorylated myosin light chain-related mechanism. PLoS One (2012) 0.81
Established and emerging approaches for the management of dyslipidaemia. Scientifica (Cairo) (2012) 0.75
Insulin resistance and vessel endothelial function. J R Soc Med (2002) 0.75
Herpes zoster is associated with prior statin use: a population-based case-control study. PLoS One (2014) 0.75
Minimizing cardiac risk in perioperative practice - interdisciplinary pharmacological approaches. Wien Klin Wochenschr (2011) 0.75
[Clinico-pharmacologic explanation models of cerivastatin associated rhabdomyolysis]. Wien Med Wochenschr (2003) 0.75
Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol (1999) 3.44
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost (2006) 2.08
Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not? Intensive Care Med (2007) 1.76
Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Wien Klin Wochenschr (2000) 1.42
Signaling in neuropeptide-induced migration of human eosinophils. J Leukoc Biol (1998) 1.15
Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol (1993) 1.13
Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol (2001) 1.12
Effect of inhibitors of Na+/H+-exchange and gastric H+/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes. Br J Pharmacol (1998) 1.09
B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J Immunol (2000) 1.07
Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood (2001) 1.05
Imported malaria: six cases of severe Plasmodium falciparum infection in Innsbruck, Austria, within a period of five weeks (February/March 1999) Wien Klin Wochenschr (2000) 1.05
Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis (2002) 1.04
A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol (1999) 1.04
Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol (1997) 1.03
Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation (2001) 1.01
RANTES chemokine expression in diseased and normal human tissues. Cytokine (1996) 0.97
Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology (1993) 0.92
Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. Circ Res (1997) 0.92
CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int J Immunopathol Pharmacol (2003) 0.90
Septicaemia and endomyocarditis caused by Aerococcus urinae. Wien Klin Wochenschr (1999) 0.90
Theoretical basis for the activity of thalidomide. BioDrugs (2001) 0.90
High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis. Minerva Anestesiol (2013) 0.88
Biochemical and functional properties of large and small dense-core vesicles in sympathetic nerves of rat and ox vas deferens. Neuroscience (1984) 0.88
Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun (2001) 0.87
Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability. Am Rev Respir Dis (1988) 0.87
Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen. Peptides (1991) 0.87
Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J Cell Physiol (1993) 0.86
Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol (1996) 0.86
Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol (1997) 0.85
Suppression of superoxide release from human monocytes by somatostatin-related peptides. Regul Pept (1992) 0.84
Functional expression of chemokine receptor 2 by normal human eosinophils. J Allergy Clin Immunol (2001) 0.84
Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2001) 0.84
Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock. Intensive Care Med (2008) 0.84
Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood (1998) 0.83
Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett (1993) 0.83
Dendritic cell migration in different micropore filter assays. Immunol Lett (2000) 0.83
Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital. J Prev Med Hyg (2009) 0.83
Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro. Immunol Lett (1997) 0.82
Human chorionic gonadotrophin: a chemoattractant for human blood monocytes, neutrophils and lymphocytes. J Endocrinol (1994) 0.82
Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol (1993) 0.82
Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine- and endotoxin-activated endothelium. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.82
Substance P receptor-mediated secretion of respiratory glycoconjugate from feline airways in vitro. Exp Lung Res (1989) 0.82
Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils. Cardiovasc Res (1998) 0.82
Bombesin in human and guinea pig alveolar macrophages. J Immunol (1986) 0.81
Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation (2001) 0.81
The role of immune activation in endotoxin-induced atherogenesis. J Endotoxin Res (2001) 0.81
The acute-phase protein alpha 1-antitrypsin inhibits transferrin-receptor binding and proliferation of human skin fibroblasts. Biochim Biophys Acta (1998) 0.81
Sudden death in a young competitive athlete with Wolff-Parkinson-White syndrome. Eur Heart J (1987) 0.81
Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide in vitro. Immunol Lett (1992) 0.81
Plasma catecholamines in arterial and capillary blood. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.81
Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase. Blood Coagul Fibrinolysis (2001) 0.81
Chromatographic analysis of gastrin-releasing peptide in heat-inactivated fetal calf serum. Cell Tissue Kinet (1986) 0.80
Syndecan-4-dependent migration of human eosinophils. Clin Exp Allergy (2004) 0.80
Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro. Arterioscler Thromb Vasc Biol (1997) 0.80
Signal transduction pathways in directed migration of human monocytes induced by human growth hormone in vitro. Int Immunopharmacol (2001) 0.80
Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction. Am Heart J (1992) 0.80
Secretoneurin-induced in vitro chemotaxis of human monocytes is inhibited by pertussis toxin and an inhibitor of protein kinase C. Neurosci Lett (1996) 0.79
Influence of neuropeptides on neutrophil adhesion and transmigration through a lung fibroblast barrier in vitro. Exp Lung Res (2001) 0.79
Neuropeptides and the immune system: focus on dendritic cells. Crit Rev Immunol (2001) 0.79
Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arterioscler Thromb Vasc Biol (1997) 0.79
Levofloxacin elimination during albumin dialysis. Int J Artif Organs (2003) 0.78
Superoxide anion release from neutrophils in growth hormone deficient adults before and after replacement therapy with recombinant human growth hormone. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.78
Contrast media-induced nephropathy in patients undergoing angiography prior to or during vascular surgery: a systematic review. Minerva Chir (2011) 0.78
Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis. J Neuroimmunol (1998) 0.78
Modulation of neutrophil migration and superoxide anion release by metoprolol. J Mol Cell Cardiol (2000) 0.78
Attenuation of leukocyte beta 2-integrin expression by antithrombin-III. Int J Immunopathol Pharmacol (2004) 0.77
Renal failure in septic patients receiving hydroxyethyl starch. Minerva Anestesiol (2007) 0.77
Specific binding of a 125I-secretoneurin analogue to a human monocytic cell line. J Neuroimmunol (1998) 0.77
High-affinity substance P binding sites of neurokinin-1 receptor type autoradiographically associated with vascular sinuses and high endothelial venules of human lymphoid tissues. Lab Invest (1993) 0.77
Neuropeptide-induced chemotaxis of eosinophils in pulmonary diseases. Ann Med (2000) 0.77
Neuropeptides and the immune system. Substance P receptors in bronchus-associated lymphoid tissue of rat. Ann N Y Acad Sci (1987) 0.77
Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by acetylsalicylic acid. Eur J Pharmacol (1994) 0.77
Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophils. Immunopharmacology (1999) 0.77
Substance P receptors in rat spleen: characterization and autoradiographic distribution. Blood (1986) 0.77
Short communicationa simple way to obtain sufficient amounts of arterial endothelial cells from human umbilical cords. Cell Biol Int (1999) 0.77
Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: a prospective study. Eur J Clin Invest (1998) 0.77
Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin. Eur J Pharmacol (1996) 0.77
Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin. Regul Pept (1996) 0.77
Decrease of respiratory burst in neutrophils of patients with ankylosing spondylitis by combined radon-hyperthermia treatment. Clin Exp Rheumatol (1999) 0.77
Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide. Immunopharmacology (1999) 0.76
Systemic hypotension on withdrawal from inhaled nitric oxide in an adult patient with acute respiratory distress syndrome. Crit Care Med (1999) 0.76
Induction of normal human eosinophil migration in vitro by substance P. Acta Haematol (1993) 0.76